Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kura Oncology (KURA) Interest Expenses (2024 - 2025)

Historic Interest Expenses for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $393000.0.

  • Kura Oncology's Interest Expenses fell 461.17% to $393000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2024, which is 451.9% up from last year.
  • As of Q3 2025, Kura Oncology's Interest Expenses stood at $393000.0, which was down 461.17% from $391000.0 recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Interest Expenses peaked at $412000.0 during Q3 2024, and registered a low of $382000.0 during Q1 2025.